10-Q: Dr. Foods, Inc. Reports Q3 2024 Results: Revenue Increases but Losses Persist Amid Going Concern Uncertainty
Quarterly Report
Dr. Foods, Inc. reports increased revenue for Q3 2024 compared to the previous year, but continues to operate at a loss with concerns about its ability to continue as a going concern.
Summary
- Dr. Foods, Inc. filed its Form 10-Q for the quarterly period ended December 31, 2023.
- The company's revenue increased to $6,967 for the three months ended December 31, 2023, compared to $167 for the same period in 2022.
- For the nine months ended December 31, 2023, revenue was $12,730, up from $167 in the corresponding period of 2022.
- The company recorded a net loss of $191,848 for the nine months ended December 31, 2023, compared to a net loss of $232,988 for the nine months ended December 31, 2022.
- As of December 31, 2023, the company's cash balance was $9,436.
- The company has a working capital deficiency and has been relying on its CEO, Koichi Ishizuka, for funding.
- There is substantial doubt about the company's ability to continue as a going concern for the next year.
- The company is pursuing the acquisition of Mama Foods Co., Ltd., but the acquisition is contingent on the completion of a PCAOB audit of Mama Foods' financial statements.
- The company identified material weaknesses in its internal controls, including domination of management by a single individual, lack of outside directors, inadequate segregation of duties, and lack of an audit committee.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the company's going concern issues, reliance on related party transactions, material weaknesses in internal controls, and the uncertainty surrounding the Mama Foods acquisition. While revenue increased, the overall financial health and operational risks outweigh this positive aspect.
Positives
- Revenue increased significantly for both the three and nine months ended December 31, 2023, compared to the same periods in 2022.
- The net loss decreased for the nine months ended December 31, 2023, compared to the same period in 2022.
Negatives
- The company continues to operate at a loss.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company is heavily reliant on its CEO for funding, with no formal commitment in place.
- Material weaknesses exist in the company's internal controls.
- The acquisition of Mama Foods is uncertain and dependent on a PCAOB audit.
Risks
- The company's ability to continue as a going concern is uncertain due to operating losses and a working capital deficiency.
- The company's reliance on its CEO for funding poses a risk, as there is no formal commitment from him.
- The acquisition of Mama Foods is uncertain and may not be completed or may not be on favorable terms.
- Material weaknesses in internal controls could lead to misstatements in financial reporting.
- The company's limited operating history and small size make it a high-risk investment.
Future Outlook
The company intends to expand its reach to customers globally in the future, but cannot forecast when that may be feasible. The company may require further funding to implement its plan of operations for the next twelve-month period.
Management Comments
- Management plans to fund operating expenses with related party contributions to capital.
- There is no assurance that management's plan will be successful.
Industry Context
The company operates in the alternative meat industry, which is experiencing growth as consumers seek plant-based options. The company's collaboration with Next Meats Co., Ltd. positions it to benefit from this trend.
Comparison to Industry Standards
- It is difficult to compare Dr. Foods directly to industry standards due to its early stage and limited revenue.
- Larger companies in the alternative meat industry, such as Beyond Meat and Impossible Foods, have significantly higher revenue and established distribution networks.
- Dr. Foods' reliance on related party transactions and the lack of a formal marketing plan are atypical compared to more established companies in the industry.
Related Party Transactions
- Dr. Foods Co. Ltd loaned funds to related party White Knight, which is owned and controlled by the CEO, Koichi Ishizuka.
- Dr. Foods Co. Ltd received invoices from related party Next Meats Co. Ltd.
- Dr. Foods Co. Ltd received invoices from related party Mama Foods.
- Dr. Foods Co. Ltd had increased borrowings from White Knight.
Stakeholder Impact
- Shareholders face a high risk of losing their investment due to the company's financial instability.
- Employees may be impacted by potential cost-cutting measures or the company's inability to continue operations.
- Customers may be affected by the company's ability to deliver products and services.
- Suppliers and creditors face the risk of non-payment due to the company's financial difficulties.
Next Steps
- Complete the PCAOB audit of Mama Foods Co., Ltd.
- Secure funding to support operations.
- Develop and implement a marketing plan for Dr. Foie Gras.
- Address the material weaknesses in internal controls.
Key Dates
| Date | Description |
|---|---|
| 2021-02-26 | Dr. Foods, Inc. was incorporated in Nevada. |
| 2021-08-24 | The Company changed its name to Dr. Foods, Inc. |
| 2021-09-17 | Dr. Foods Co., Ltd. was incorporated as a wholly owned subsidiary in Japan. |
| 2021-10-11 | Dr. Foods Co., Ltd. entered into a Collaboration Agreement with Next Meats Co., Ltd. |
| 2021-10-11 | Three new executive officers were appointed to Dr. Foods Co., Ltd. |
| 2021-11-03 | Dr. Foods, Inc. began trading under the symbol DRFS. |
| 2022-01-12 | Dr. Foods, Inc., Mama Foods Co., Ltd., and White Knight Co., Ltd. entered into a non-definitive agreement (Letter of Intent) for Dr. Foods to acquire Mama Foods. |
| 2022-03-31 | Dr. Foods, Inc. and Mama Foods mutually agreed to extend the terms of the non-definitive agreement 30 more days. |
| 2022-04-01 | Patent application filed with the Japanese Patent Office for the production method of Dr. Foie Gras. |
| 2022-05-06 | The parties again agreed to extend the terms of the non-definitive agreement, however this time with an expiration date of June 30, 2022, or until, if agreed upon by all parties, further notice. |
| 2022-05-31 | We sold 1,538,462 shares of restricted Common Stock to SJ Capital Co., Ltd., a Japanese Company, for proceeds totaling approximately $769,231. |
| 2022-06-30 | The non-definitive agreement terminated without the books and records of Mama Foods Co., Ltd. having been prepared or progressed to the satisfaction of the Issuer. |
| 2022-07-01 | NXMH sold 5,000 shares of Series Z Preferred Stock of DRFS, to WKC, at a price of approximately $147,624 USD (20,000,000 Japanese Yen). |
| 2022-09-13 | The Company filed a certificate of change (the certificate) with the Nevada Secretary of State to effect a reverse stock split. |
| 2022-09-21 | The effective date of the certificate was September 21, 2022. |
| 2022-09-27 | The FINRA Daily List Announcement Date was on September 27, 2022. |
| 2022-09-28 | The Market Effective Date of the Reverse Stock Split, which was on September 28, 2022. |
| 2022-10-17 | DR FOODS (S) PTE. LTD., a Singapore Private Company limited by shares was incorporated. |
| 2023-03-31 | End of fiscal year. |
| 2023-06-26 | The company consummated an agreement for the sale of 593,811 shares of restricted Common Stock to Ultimate One LLC, a Japanese Company, at a price of $0.315 per share of Common Stock. |
| 2023-09-30 | The transaction was completed, and recorded by the Companys transfer agent, on September 30, 2023. |
| 2023-12-31 | End of quarterly period. |
| 2024-02-12 | Date of report. |
Keywords
financial statements, going concern, related party transactions, revenue, net loss, internal controls, acquisition, Mama Foods, Dr. Foods
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.